Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Sees Large Increase in Short Interest

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the recipient of a significant increase in short interest in May. As of May 29th, there was short interest totaling 33,275 shares, an increase of 114.3% from the May 14th total of 15,525 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Towa Pharmaceutical Stock Performance

Shares of OTCMKTS:TWAPF opened at $25.33 on Monday. Towa Pharmaceutical has a 1 year low of $16.83 and a 1 year high of $25.33. The business has a fifty day moving average price of $25.33 and a two-hundred day moving average price of $25.33.

Analyst Ratings Changes

Separately, Morgan Stanley upgraded Towa Pharmaceutical to an “overweight” rating in a report on Friday. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy”.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.